doi: 10.1016/0014-2999(88)90644-9.
Labeling of A1 adenosine receptors in porcine atria with the antagonist radioligand 8-cyclopentyl-1,3-[3H]dipropylxanthine
Affiliations
- PMID: 3371409
- DOI: 10.1016/0014-2999(88)90644-9
Item in Clipboard
Labeling of A1 adenosine receptors in porcine atria with the antagonist radioligand 8-cyclopentyl-1,3-[3H]dipropylxanthine
Eur J Pharmacol.
.
Abstract
We have used the antagonist radioligand 8-cyclopentyl-1,3-[3H]dipropylxanthine to label adenosine recognition sites in porcine atrial membranes. 8-Cyclopentyl-1,3-[3H]dipropylxanthine bound saturably, reversibly and with high affinity to an apparently homogeneous population of recognition sites with a Bmax of 32.0 +/- 0.9 fmol/mg protein and a KD of 0.394 +/- 0.049 nM. Prototypic adenosine receptor agonists inhibited the specific binding of 8-cyclopentyl-1,3-[3H]dipropylxanthine in a manner consistent with the labeling of an A1 adenosine receptor. 8-Cyclopentyl-1,3-[3H]dipropylxanthine appears to be a valuable antagonist radioligand for the characterization of cardiac adenosine receptors.
Similar articles
-
Characterization of adenosine binding sites in bovine testicular tissue using 8-cyclopentyl-1,3-[3H]dipropylxanthine.Eur J Pharmacol. 1988 Aug 2;152(3):353-6. doi: 10.1016/0014-2999(88)90731-5. Eur J Pharmacol. 1988. PMID: 3220109
-
Characterization of cardiac A1 adenosine receptors with the antagonist radioligand 8-cyclopentyl-1,3[3H]-dipropylxanthine.Proc West Pharmacol Soc. 1988;31:103. Proc West Pharmacol Soc. 1988. PMID: 3211886 No abstract available.
-
Characterization of the adenosine receptor in cultured embryonic chick atrial myocytes: coupling to modulation of contractility and adenylate cyclase activity and identification by direct radioligand binding.J Pharmacol Exp Ther. 1989 Jun;249(3):775-84. J Pharmacol Exp Ther. 1989. PMID: 2732946
-
The adenosine A3 receptor and its ligands.Prog Med Chem. 2001;38:61-113. doi: 10.1016/s0079-6468(08)70092-4. Prog Med Chem. 2001. PMID: 11774799 Review. No abstract available.
-
[Adenosine receptor ligands--drugs of the future?].Pharm Unserer Zeit. 1989 May;18(3):65-75. doi: 10.1002/pauz.19890180302. Pharm Unserer Zeit. 1989. PMID: 2657803 Review. German. No abstract available.
Cited by
-
Characterization of the K(+)-channel-coupled adenosine receptor in guinea pig atria.Naunyn Schmiedebergs Arch Pharmacol. 1989 Dec;340(6):684-8. doi: 10.1007/BF00717745. Naunyn Schmiedebergs Arch Pharmacol. 1989. PMID: 2615858
-
The binding of 1,3-[3H]-dipropyl-8-cyclopentylxanthine to adenosine A1 receptors in rat smooth muscle preparations.Br J Pharmacol. 1994 Dec;113(4):1249-56. doi: 10.1111/j.1476-5381.1994.tb17132.x. Br J Pharmacol. 1994. PMID: 7889280 Free PMC article.
-
A1 adenosine receptors can occur manifesting two kinetic components of 8-cyclopentyl-1,3-[3H]dipropylxanthine ([3H]DPCPX) binding.Naunyn Schmiedebergs Arch Pharmacol. 1994 May;349(5):485-91. doi: 10.1007/BF00169137. Naunyn Schmiedebergs Arch Pharmacol. 1994. PMID: 8065462
-
Adenosine receptors and nucleoside transport sites in cardiac cells.Br J Pharmacol. 1991 Oct;104(2):399-405. doi: 10.1111/j.1476-5381.1991.tb12442.x. Br J Pharmacol. 1991. PMID: 1797306 Free PMC article.
-
Characterization of adenosine receptors in intact cultured heart cells.Biochem Pharmacol. 1994 Aug 17;48(4):727-35. doi: 10.1016/0006-2952(94)90050-7. Biochem Pharmacol. 1994. PMID: 8080445 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
